Title:Co-morbidity of Covid-19 and Stenotrophomonas maltophilia in a Patient
with Hodgkin's Lymphoma History from North of Iran
Volume: 21
Issue: 8
Author(s): David Darvishnia, Mahdieh Sadeghi, Ali Sharifpour, Zakaria Zakariaei*, Elham Sadat Banimostafavi, Mahdi Fakhar and Rabeeh Tabaripour
Affiliation:
- Toxicology and Forensic Medicine Division, Orthopedic Research Center, Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, ,Iraq
Abstract:
Introduction: Immunocompromised patients, especially those hospitalized, are at a higher
risk for infection with opportunistic pathogens such as Stenotrophomonas maltophilia (S. maltophilia)
which is a multidrug-resistant gram-negative bacillus and can cause a challenge in the management
of patients with concomitant COVID-19 and S. maltophilia pneumonia.
Case Presentation: A 71-year-old man with Hodgkin's lymphoma presented with severe respiratory
symptoms of COVID-19 was intubated upon admission and the initial standard treatment for
COVID-19 was started for him. The patient subsequently developed superimposed bacterial pneumonia
with S. maltophilia. According to that, the patient's intubation tube was removed and a
tracheostomy was performed for him. Also, antibiotic treatment was replaced with Colistin and
Co-trimoxazole drugs. Finally, after 31 days of hospitalization in the ICU and the appropriate drug
treatment, he was discharged with reduced symptoms and partial recovery.
Conclusion: It should be noted that the occurrence of co-infection with multidrug-resistant pathogens
such as S. maltophilia requires proper management to select appropriate treatment methods
and drugs, so that in addition to proper effectiveness, it does not lead to side effects and complications
associated with COVID-19 disease.
